{"id":5862,"date":"2009-07-07T00:00:00","date_gmt":"2009-07-07T04:00:00","guid":{"rendered":"https:\/\/icesontario.wpengine.com\/journal-articles\/long-term-trends-in-use-of-and-expenditures-for-cardiovascular-medications-in-canada\/"},"modified":"2023-06-14T19:53:28","modified_gmt":"2023-06-14T23:53:28","slug":"long-term-trends-in-use-of-and-expenditures-for-cardiovascular-medications-in-canada","status":"publish","type":"journal_article","link":"https:\/\/www.ices.on.ca\/fr\/publications\/journal-articles\/long-term-trends-in-use-of-and-expenditures-for-cardiovascular-medications-in-canada\/","title":{"rendered":"Long-term trends in use of and expenditures for cardiovascular medications in Canada"},"content":{"rendered":"<p><strong>Background<\/strong> &#x2014; Medication expenditures have become the fastest growing sector of costs within the Canadian healthcare system. Evaluation of the use of cardiovascular medications is important to determine the magnitude of the growth, to identify which medications dominate the landscape and to detect interprovincial differences in utilization. We describe long-term trends in the use of and expenditures for cardiovascular medications in Canada, by drug class and by province.<\/p>\n<p><strong>Methods<\/strong> &#x2014; For these analyses, we used volume and expenditure data related to prescriptions for cardiovascular medications obtained from IMS Health Canada&apos;s CompuScript Audit database for the period 1996-2006. Here, we describe national and provincial patterns of utilization and expenditures for specified classes of cardiovascular medications.<\/p>\n<p><strong>Results<\/strong> &#x2014; The use of cardiovascular medications increased sharply in Canada during the study period, with related costs rising by over 200% during this period to surpass &#x24;5 billion in 2006. Changes in population demographics, risk factors and inflation appeared to account for about two-thirds of the observed growth in expenditures. Use of newer medication classes (statins, angiotensin-receptor blockers, angiotensin-converting-enzyme inhibitors), for which patented brand name medications predominate, accounted for almost one-third of the cost increases. Interprovincial differences in total expenditures for cardiovascular drugs portrayed a descending gradient from east to west, with greatest variability for the newer drug classes.<\/p>\n<p><strong>Interpretation<\/strong> &#x2014; Prescriptions and expenditures for cardiovascular medications in Canada escalated over the study period. Projected increases may reach potentially unsustainable levels. Greater emphasis on the use of cost-effective medications is required to limit further increases. Factors influencing interprovincial differences warrant further study.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Background &#x2014; Medication expenditures have become the fastest growing sector of costs within the Canadian healthcare system. Evaluation of the use of cardiovascular medications is important to determine the magnitude of the growth, to identify which medications dominate the landscape and to detect interprovincial differences in utilization. We describe long-term trends in the use of [&hellip;]<\/p>\n","protected":false},"template":"","migration-helper-automated":[],"migration-manual":[],"topic":[61,62,56],"migration-helper-qa-sample-set":[],"class_list":["post-5862","journal_article","type-journal_article","status-publish","hentry","topic-health-economics","topic-health-services-research","topic-pharmacoepidemiology-and-drug-safety"],"acf":{"citation":"Jackevicius CA, Cox JL, Carreon D, Tu JV, Rinfret S, So D, Johansen H, Kalavrouziotis D, Demers V, Humphries K, Pilote L; Canadian Cardiovascular Outcomes Research Team. <em>CMAJ<\/em>. 2009; 181(1-2):E19-28.","source_url":"http:\/\/www.cmaj.ca\/content\/181\/1-2\/E19.long","ices_scientist":[1281],"site":[6733],"research_program":[6742],"news_release":[7905],"journal_article":[],"atlas":[],"research_report":[],"infographic":[],"video":[],"downloads":null,"links":null,"sitecore_item_id":"6BAD2797-880F-4415-8E47-A1CCB78ABA76","sitecore_item_name":"Long-term-trends-in-use-of-and-expenditures-for-cardiovascular-medications-in-Canada","sitecore_field_values":"{\n  \"Title\": \"Long-term trends in use of and expenditures for cardiovascular medications in Canada\",\n  \"Short title\": \"Long-term trends in use\",\n  \"Citation\": \"<p>Jackevicius CA, Cox JL, Carreon D, Tu JV, Rinfret S, So D, Johansen H, Kalavrouziotis D, Demers V, Humphries K, Pilote L; Canadian Cardiovascular Outcomes Research Team. <em>CMAJ<\/em>. 2009; 181(1-2):E19-28.<\/p>\",\n  \"Abstract\": \"<p><strong>Background<\/strong> &mdash; Medication expenditures have become the fastest growing sector of costs within the Canadian healthcare system. Evaluation of the use of cardiovascular medications is important to determine the magnitude of the growth, to identify which medications dominate the landscape and to detect interprovincial differences in utilization. We describe long-term trends in the use of and expenditures for cardiovascular medications in Canada, by drug class and by province.<\/p>n<p><strong>Methods<\/strong> &mdash; For these analyses, we used volume and expenditure data related to prescriptions for cardiovascular medications obtained from IMS Health Canada's CompuScript Audit database for the period 1996-2006. Here, we describe national and provincial patterns of utilization and expenditures for specified classes of cardiovascular medications.<\/p>n<p><strong>Results<\/strong> &mdash; The use of cardiovascular medications increased sharply in Canada during the study period, with related costs rising by over 200% during this period to surpass $5 billion in 2006. Changes in population demographics, risk factors and inflation appeared to account for about two-thirds of the observed growth in expenditures. Use of newer medication classes (statins, angiotensin-receptor blockers, angiotensin-converting-enzyme inhibitors), for which patented brand name medications predominate, accounted for almost one-third of the cost increases. Interprovincial differences in total expenditures for cardiovascular drugs portrayed a descending gradient from east to west, with greatest variability for the newer drug classes.<\/p>n<p><strong>Interpretation<\/strong> &mdash; Prescriptions and expenditures for cardiovascular medications in Canada escalated over the study period. Projected increases may reach potentially unsustainable levels. Greater emphasis on the use of cost-effective medications is required to limit further increases. Factors influencing interprovincial differences warrant further study.<\/p>n<p><a href=\"http:\/\/www.cmaj.ca\/content\/181\/1-2\/E19.long\" title=\"Opens external link\">View full text<\/a><\/p>\",\n  \"Keywords\": \"{D4620196-76F6-4AE4-9103-FB996B44FAC4}|{002C9B1A-B097-4316-A26A-BA3C0A3B8FA9}|{5B386094-8417-4B93-9D08-2F46BC0458AB}\",\n  \"Related Products\": \"<h2>News Release<\/h2>rn<h3><a href=\"~\/link.aspx?_id=002BC0614B5C4C7C9FAA5AEEAC65E86F&amp;_z=z\">Canadian spending on heart drugs doubles to more than $5 billion a year<\/a><\/h3>\",\n  \"Research Programs\": \"{BEC72DE0-BA8C-42B8-ACE5-EE29FFB2CB3B}\",\n  \"ICES Locations\": \"{4FCAABBA-14A5-42E6-8F33-BC6C2F1D9908}\",\n  \"ICES Scientists\": \"{BA86E62A-3468-443D-939F-34A9EFA7B7AA}|{956599EC-5699-41D3-9375-E0B6C25B12D5}\",\n  \"Posted Date\": \"20090707T000000\"\n}","previous_url":"https:\/\/www.ices.on.ca\/Publications\/Journal-Articles\/2009\/January\/Long-term-trends-in-use-of-and-expenditures-for-cardiovascular-medications-in-Canada"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ICES | Long-term trends in use of and expenditures for cardiovascular medications in Canada<\/title>\n<meta name=\"description\" content=\"Background &#x2014; Medication expenditures have become the fastest growing sector of costs within the Canadian healthcare system. Evaluation of the use\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ices.on.ca\/fr\/publications\/journal-articles\/long-term-trends-in-use-of-and-expenditures-for-cardiovascular-medications-in-canada\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ICES | Long-term trends in use of and expenditures for cardiovascular medications in Canada\" \/>\n<meta property=\"og:description\" content=\"Background &#x2014; Medication expenditures have become the fastest growing sector of costs within the Canadian healthcare system. Evaluation of the use\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ices.on.ca\/fr\/publications\/journal-articles\/long-term-trends-in-use-of-and-expenditures-for-cardiovascular-medications-in-canada\/\" \/>\n<meta property=\"og:site_name\" content=\"ICES\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ICESOntario\/\" \/>\n<meta property=\"article:modified_time\" content=\"2023-06-14T23:53:28+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.ices.on.ca\/wp-content\/uploads\/2024\/11\/ic-es-data-discovery-better-health-logo.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"675\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/publications\\\/journal-articles\\\/long-term-trends-in-use-of-and-expenditures-for-cardiovascular-medications-in-canada\\\/\",\"url\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/publications\\\/journal-articles\\\/long-term-trends-in-use-of-and-expenditures-for-cardiovascular-medications-in-canada\\\/\",\"name\":\"ICES | Long-term trends in use of and expenditures for cardiovascular medications in Canada\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/#website\"},\"datePublished\":\"2009-07-07T04:00:00+00:00\",\"dateModified\":\"2023-06-14T23:53:28+00:00\",\"description\":\"Background &#x2014; Medication expenditures have become the fastest growing sector of costs within the Canadian healthcare system. Evaluation of the use\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/publications\\\/journal-articles\\\/long-term-trends-in-use-of-and-expenditures-for-cardiovascular-medications-in-canada\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/publications\\\/journal-articles\\\/long-term-trends-in-use-of-and-expenditures-for-cardiovascular-medications-in-canada\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/publications\\\/journal-articles\\\/long-term-trends-in-use-of-and-expenditures-for-cardiovascular-medications-in-canada\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Journal Articles\",\"item\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/publications\\\/journal-articles\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Long-term trends in use of and expenditures for cardiovascular medications in Canada\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/\",\"name\":\"ICES\",\"description\":\"POPULATION-BASED HEALTH RESEARCH THAT MAKES A DIFFERENCE\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/#organization\"},\"alternateName\":\"Institute for Clinical Evaluative Sciences\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/#organization\",\"name\":\"ICES\",\"alternateName\":\"Institute for Clinical Evaluative Sciences\",\"url\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.ices.on.ca\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/ices-logo.png\",\"contentUrl\":\"https:\\\/\\\/www.ices.on.ca\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/ices-logo.png\",\"width\":\"676\",\"height\":\"618\",\"caption\":\"ICES\"},\"image\":{\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/ICESOntario\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/ices-research-institute\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ICES | Long-term trends in use of and expenditures for cardiovascular medications in Canada","description":"Background &#x2014; Medication expenditures have become the fastest growing sector of costs within the Canadian healthcare system. Evaluation of the use","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ices.on.ca\/fr\/publications\/journal-articles\/long-term-trends-in-use-of-and-expenditures-for-cardiovascular-medications-in-canada\/","og_locale":"fr_FR","og_type":"article","og_title":"ICES | Long-term trends in use of and expenditures for cardiovascular medications in Canada","og_description":"Background &#x2014; Medication expenditures have become the fastest growing sector of costs within the Canadian healthcare system. Evaluation of the use","og_url":"https:\/\/www.ices.on.ca\/fr\/publications\/journal-articles\/long-term-trends-in-use-of-and-expenditures-for-cardiovascular-medications-in-canada\/","og_site_name":"ICES","article_publisher":"https:\/\/www.facebook.com\/ICESOntario\/","article_modified_time":"2023-06-14T23:53:28+00:00","og_image":[{"width":1200,"height":675,"url":"https:\/\/www.ices.on.ca\/wp-content\/uploads\/2024\/11\/ic-es-data-discovery-better-health-logo.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.ices.on.ca\/fr\/publications\/journal-articles\/long-term-trends-in-use-of-and-expenditures-for-cardiovascular-medications-in-canada\/","url":"https:\/\/www.ices.on.ca\/fr\/publications\/journal-articles\/long-term-trends-in-use-of-and-expenditures-for-cardiovascular-medications-in-canada\/","name":"ICES | Long-term trends in use of and expenditures for cardiovascular medications in Canada","isPartOf":{"@id":"https:\/\/www.ices.on.ca\/fr\/#website"},"datePublished":"2009-07-07T04:00:00+00:00","dateModified":"2023-06-14T23:53:28+00:00","description":"Background &#x2014; Medication expenditures have become the fastest growing sector of costs within the Canadian healthcare system. Evaluation of the use","breadcrumb":{"@id":"https:\/\/www.ices.on.ca\/fr\/publications\/journal-articles\/long-term-trends-in-use-of-and-expenditures-for-cardiovascular-medications-in-canada\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ices.on.ca\/fr\/publications\/journal-articles\/long-term-trends-in-use-of-and-expenditures-for-cardiovascular-medications-in-canada\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.ices.on.ca\/fr\/publications\/journal-articles\/long-term-trends-in-use-of-and-expenditures-for-cardiovascular-medications-in-canada\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.ices.on.ca\/fr\/"},{"@type":"ListItem","position":2,"name":"Journal Articles","item":"https:\/\/www.ices.on.ca\/fr\/publications\/journal-articles\/"},{"@type":"ListItem","position":3,"name":"Long-term trends in use of and expenditures for cardiovascular medications in Canada"}]},{"@type":"WebSite","@id":"https:\/\/www.ices.on.ca\/fr\/#website","url":"https:\/\/www.ices.on.ca\/fr\/","name":"ICES","description":"POPULATION-BASED HEALTH RESEARCH THAT MAKES A DIFFERENCE","publisher":{"@id":"https:\/\/www.ices.on.ca\/fr\/#organization"},"alternateName":"Institute for Clinical Evaluative Sciences","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ices.on.ca\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.ices.on.ca\/fr\/#organization","name":"ICES","alternateName":"Institute for Clinical Evaluative Sciences","url":"https:\/\/www.ices.on.ca\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.ices.on.ca\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.ices.on.ca\/wp-content\/uploads\/2023\/04\/ices-logo.png","contentUrl":"https:\/\/www.ices.on.ca\/wp-content\/uploads\/2023\/04\/ices-logo.png","width":"676","height":"618","caption":"ICES"},"image":{"@id":"https:\/\/www.ices.on.ca\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ICESOntario\/","https:\/\/www.linkedin.com\/company\/ices-research-institute\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/journal_article\/5862","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/journal_article"}],"about":[{"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/types\/journal_article"}],"acf:post":[{"embeddable":true,"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/news_release\/7905"},{"embeddable":true,"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/research_program\/6742"},{"embeddable":true,"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/site\/6733"},{"embeddable":true,"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/ices_scientist\/1281"}],"wp:attachment":[{"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/media?parent=5862"}],"wp:term":[{"taxonomy":"migration-helper-automated","embeddable":true,"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/migration-helper-automated?post=5862"},{"taxonomy":"migration-manual","embeddable":true,"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/migration-manual?post=5862"},{"taxonomy":"topic","embeddable":true,"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/topic?post=5862"},{"taxonomy":"migration-helper-qa-sample-set","embeddable":true,"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/migration-helper-qa-sample-set?post=5862"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}